Investor Relations

Investor Relations

About Vascular Technologies, Inc.

Vascular Technologies, Inc. is a fast-growing medical device company in the United States. Our principal product is the Ultroid® Hemorrhoid Management System, a non-invasive, pain-free, and lower cost treatment than current procedures for the treatment of hemorrhoidal disease (HD).

October 2011 Shareholder Update

Ultroid®'s Board of Directors met during the week of September 26, 2011. A revised schedule of monthly conference calls and quarterly face to face meetings have been established. The various committees and project scopes/timelines have also been revised. Ultroid®'s next shareholder newletter will be sent within the next couple of weeks, which will also be placed here for easy viewing. From all of us at Ultroid®, thank you for your continued support and patience.

September 2011 Shareholder Update

To all Ultroid® shareholders, thank you for your patience and continued support. The Board of Directors will be meeting the week of September 26, 2011. A shareholder newsletter has been sent to everyone. You can also view it by clicking here. This newsletter is the first of many. It will answer questions and spark new questions for discussion during the next shareholder meeting, which will be shortly after the Board of Directors meet. If you have any questions, Michael Knox, President and CEO is always available to speak with individual shareholders. Please feel free to call the office or send him an email to This email address is being protected from spambots. You need JavaScript enabled to view it. . Again, thank you for your patience and continued support. The answers and updates are coming very soon.

For more information about investing in Vascular Technologies, Inc., please contact our Investor Relations Team: This email address is being protected from spambots. You need JavaScript enabled to view it. .